Physician profile
Benjamin S Chudner
NPI 1063416485
$16,364.07
in general payments reported to CMS, 2019-2025
19 companies · $3,187 in 2025
The $3,187 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,658 · 2020: $188 · 2021: $808 · 2022: $3,403 · 2023: $3,354 · 2024: $3,765 · 2025: $3,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,969 · Travel and Lodging: $2,910 · Entertainment: $2,028 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,969.27 |
| Travel and Lodging | $2,909.58 |
| Entertainment | $2,027.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $4,632.98 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $2,434.48 | 2019-2025 | Cvi Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $2,178.17 | 2023-2025 | |
| Johnson & Johnson Vision Care, INC. | $2,011.81 | 2019-2024 | |
| Lkc Technologies, INC. | $1,989.62 | 2022-2025 | |
| Sight Sciences, INC. | $896.10 | 2019-2022 | |
| Notal Vision, INC. | $400.00 | 2025 | Foresee Home |
| Abbvie INC. | $341.08 | 2022-2024 | |
| Alcon Vision LLC | $316.87 | 2019-2022 | |
| Allergan, INC. | $272.78 | 2019-2022 | |
| Lombart Brothers, INC. | $217.87 | 2024 | Opd-III |
| Topcon Healthcare, INC. | $140.80 | 2024 | |
| Bausch & Lomb Americas INC. | $135.60 | 2022 | |
| Glaukos Corporation | $100.86 | 2024 | Radius |
| Kala Pharmaceuticals, INC. | $85.92 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $67.25 | 2022-2024 | Cirrus Hd-Oct |
| Johnson & Johnson Surgical Vision, INC. | $64.70 | 2021-2025 | Lipiflow System Activator (Disposable) |
| Maculogix, INC. | $56.30 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Chudner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.